Percutaneous coronary interventions with an endothelial progenitor cell capture stent (EPC) for high risk patients with no option for drug eluting stents: long term clinical outcomes of a single centre registry

Paolo Scacciatella1, MD; Emanuele Meliga2*, MD, PhD, FESC; Maurizio D’Amico1, MD; Gianluca Amato1, MD; Mauro Pennone1, MD; Federico Conrotto1, MD; Sebastiano Marra1, MD, FESC

1. Interventional Cardiology Department, San Giovanni Battista Hospital, Turin, Italy; 2. Interventional Cardiology Unit, Ordine Mauriziano Hospital, Turin, Italy

Aims: Drug eluting stents (DES) are currently considered the gold standard for reducing restenosis of coronary artery lesions. Owing to their effect on the healing process, DES use requires

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

percutaneous coronary interventionsendothelial progenitor cellsdual antiplatelet therapy

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry